Glucosamine medication

RX_GLUCOSAMINE

No definition available.

Endpoint definition

↥
FinnGen phenotype data

392423 individuals

diagram downward connector

Apply sex-specific rule None

392423

diagram downward connector

Check conditions None

392423

diagram downward connector
diagram bullet

Check pre-conditions, main-only, mode, registry filters

Medicine purchases: ATC M01AX05

1 out of 7 registries used, show all original rules.

18811

diagram downward connector
diagram bullet

Check minimum number of events

Min. number of events 3

18811

diagram downward connector

Include endpoints None

18811

diagram downward connector
diagram bullet diagram downward connector

Remove individuals based on genotype QC

18341

diagram downward connector
RX_GLUCOSAMINE

Control definitions

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze DF5

Summary Statistics

↥

Key figures

All Female Male
Number of individuals 18341 12850 5491
Unadjusted prevalence (%) 4.86 6.10 3.30
Mean age at first event (years) 60.45 59.97 61.58

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.02 1.19 [1.02, 1.39] 2.4e-2 1896
15 years 0.01 1.11 [0.96, 1.29] 1.7e-1 1524
5 years 0.00 0.97 [0.83, 1.14] 7.4e-1 306
1 year 0.00 0.30 [0.18, 0.49] 2.4e-6 16

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: RX_GLUCOSAMINE – Glucosamine medication
GWS hits: 1

Survival analyses between endpoints

↥

Plot

before Glucosamine medication
after Glucosamine medication

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Glucosamine medication

↥

Endpoint not on priority list, no data to show.